Age-Based Difference in Activation Markers of Coagulation and Fibrinolysis in Extracorporeal Membrane Oxygenation

被引:35
作者
Hundalani, Shilpa G. [1 ,2 ]
Nguyen, Kim T. [3 ]
Soundar, Esther [3 ]
Kostousov, Vadim [3 ]
Bomgaars, Lisa [2 ,4 ,5 ]
Moise, Alicia [1 ,2 ]
Hui, Shiu-Ki R. [3 ]
Teruya, Jun [2 ,3 ,6 ]
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Sect Neonatol, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA
[4] Texas Childrens Hosp, Baylor Coll Med, Ctr Canc, Houston, TX 77030 USA
[5] Texas Childrens Hosp, Baylor Coll Med, Hematol Ctr, Houston, TX 77030 USA
[6] Texas Childrens Hosp, Baylor Coll Med, Dept Med, Houston, TX 77030 USA
关键词
coagulation; extracorporeal membrane oxygenation; fibrinolysis; hemostasis; pediatric; plasmin-alpha (2)-antiplasmin complex; prothrombin fragment 1+2; thrombosis; DEVELOPMENTAL HEMOSTASIS; ANTICOAGULATION; MANAGEMENT; SYSTEM; HEMORRHAGE; IMPACT;
D O I
10.1097/PCC.0000000000000107
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Coagulation system activation in extracorporeal membrane oxygenation results in hemostatic derangements. Thrombin generation markers like prothrombin fragment 1+2 and tthrombin-antithrombin complex are sensitive markers of hypercoagulability. Plasmin-antiplasmin complex is a sensitive marker for fibrinolysis. D-dimers reflect thrombin generation and fibrinolysis. The aim was to identify the extent of hemostasis activation during extracorporeal membrane oxygenation by measuring thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer. Design: Prospective cohort study. Setting: Tertiary care academic center. Patients: Children placed on extracorporeal membrane oxygenation from April 2011 to January 2013. Interventions: Prothrombin fragment 1+2, thrombin-antithrombin complex, plasmin-antiplasmin complex, and D-dimer were measured on days 1 and 5 of extracorporeal membrane oxygenation. Measurements and Main Results: Data presented as median (interquartile range); nonparametric tests were done using SPSS. Twenty-nine children (52% < 30 d old [neonates], median extracorporeal membrane oxygenation length 151 hr) were studied. Complications included thrombosis in 14%, bleeding in 45%, and thrombosis and bleeding together in 10%. Thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D- dimer levels were high on day 1 and remained increased on extracorporeal membrane oxygenation. In neonates, all levels were higher on day 5 compared with day 1: thrombin-antithrombin complex (55.6 mu g/L [30.7-76.0] vs 18.7 mu g/L [10.9-34.6]; p = 0.03), prothrombin fragment 1+2 (2,038 pmol/L [1,093-4,018.5] vs 377.5 pmol/L [334.3-1,103.0]; p = 0.00), plasmin-antiplasmin complex (2,160 mu g/L [786-3,090] vs 398 mu g/L [296.8- 990.8]; p = 0.00), and D-dimer (3.0 mu g/mL [1.9-11.5] vs 1.5 mu g/mL [0.6-2.9]; p = 0.01). Thrombin-antithrombin complex, prothrombin fragment 1+2,plasmin-antiplasmin complex, and D-dimer levels did not correlate with anti-Xa activity or heparin dose. In bleeders older than 30 days, plasmin-antiplasmin complex stayed elevated on day 5, but in patients with no bleeding complications, plasmin-antiplasmin level showed a declining trend. In neonates, plasmin-antiplasmin levels increased over the course of extracorporeal membrane oxygenation irrespective of bleeding. Conclusion: Despite our best efforts at adequate anticoagulation with unfractionated heparin, neonates showed persistent increase in coagulation activation on extracorporeal membrane oxygenation. Fibrinolysis activation may contribute to bleeding in patients older than 30 days. Different anticoagulation protocols should be individualized based on age
引用
收藏
页码:E198 / E205
页数:8
相关论文
共 32 条
[1]   Use of a novel anticoagulation strategy during ECMO in a pediatric population:: Single-center experience [J].
Agati, Salvatore ;
Ciccarello, Giuseppe ;
Salvo, Dario ;
Turla, Giancarlo ;
Uendar, Akif ;
Mignosa, Carmelo .
ASAIO JOURNAL, 2006, 52 (05) :513-516
[2]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[3]  
ANDREW M, 1995, THROMB HAEMOSTASIS, V74, P415
[4]  
[Anonymous], PERINATAL THROMBOSIS
[5]   Indications of coagulation and/or fibrinolytic system activation in healthy and sick very-low-birth-weight neonates [J].
Aronis, S ;
Platokouki, H ;
Photopoulos, S ;
Adamtziki, E ;
Xanthou, M .
BIOLOGY OF THE NEONATE, 1998, 74 (05) :337-344
[6]  
Asakura Hidesaku, 2011, Rinsho Byori, V59, P970
[7]   Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival [J].
Baird, Christopher W. ;
Zurakowski, David ;
Robinson, Barbara ;
Gandhi, Sanjiv ;
Burdis-Koch, Leighann ;
Tamblyn, Joseph ;
Munoz, Ricardo ;
Fortich, Karol ;
Pigula, Frank A. .
ANNALS OF THORACIC SURGERY, 2007, 83 (03) :912-920
[8]   Variability in Anticoagulation Management of Patients on Extracorporeal Membrane Oxygenation: An International Survey [J].
Bembea, Melania M. ;
Annich, Gail ;
Rycus, Peter ;
Oldenburg, Gary ;
Berkowitz, Ivor ;
Pronovost, Peter .
PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (02) :E77-E84
[9]   Extracorporeal Life Support Registry Report 2004 [J].
Conrad, SA ;
Rycus, PT ;
Dalton, H .
ASAIO JOURNAL, 2005, 51 (01) :4-10
[10]   Biomarker response to drotrecogin alfa (activated) in children with severe sepsis: Results from the RESOLVE clinical trial [J].
Dalton, Heidi J. ;
Carcillo, Joseph A. ;
Woodward, D. Bradley ;
Short, Mary A. ;
Williams, Mark D. .
PEDIATRIC CRITICAL CARE MEDICINE, 2012, 13 (06) :639-645